| Enriched cancer pathway | Genes under regulation | P value |
|---|
| Fc gamma R.mediated phagocytosis |
6 genes: CFL2, FCGR2A, AMPH, PRKCA, MAPK1, FCGR2C
|
0.0003459 |
| Long.term potentiation |
5 genes: GNAQ, PRKCA, MAPK1, CACNA1C, CAMK2A
|
0.0006205 |
| Long.term depression |
5 genes: GNAO1, GNAQ, IGF1, PRKCA, MAPK1
|
0.0006205 |
| Ras signaling pathway |
8 genes: FGF2, IGF1, PDGFD, FGFR2, KDR, RASA4, MAPK1, PRKCA
|
0.002339 |
| GnRH signaling pathway |
5 genes: GNAQ, PRKCA, MAPK1, CACNA1C, CAMK2A
|
0.003182 |
| Melanogenesis |
5 genes: GNAO1, GNAQ, PRKCA, MAPK1, CAMK2A
|
0.003182 |
| Focal adhesion |
7 genes: IGF1, KDR, PRKCA, MAPK1, CCND1, PDGFD, ITGA8
|
0.003642 |
| Gastric acid secretion |
4 genes: GNAQ, KCNK2, PRKCA, CAMK2A
|
0.006033 |
| PI3K AKT signaling pathway |
9 genes: FGF2, IGF1, PDGFD, FGFR2, KDR, MAPK1, ITGA8, PRKCA, CCND1
|
0.007951 |
| Aldosterone.regulated sodium reabsorption |
3 genes: IGF1, PRKCA, MAPK1
|
0.008036 |
| Axon guidance |
5 genes: CFL2, MAPK1, SEMA6A, UNC5C, NTN1
|
0.009171 |
| Gap junction |
4 genes: GNAQ, PRKCA, MAPK1, PDGFD
|
0.01188 |
| Wnt signaling pathway |
5 genes: PRKCA, CCND1, SFRP1, TBL1X, CAMK2A
|
0.01666 |
| Regulation of actin cytoskeleton |
6 genes: CFL2, FGF2, FGFR2, MAPK1, PDGFD, ITGA8
|
0.01911 |
| Vascular smooth muscle contraction |
4 genes: GNAQ, PRKCA, MAPK1, CACNA1C
|
0.02741 |
| p53 signaling pathway |
3 genes: SESN3, IGF1, CCND1
|
0.03029 |
| VEGF signaling pathway |
3 genes: KDR, PRKCA, MAPK1
|
0.03869 |
| MAPK signaling pathway |
6 genes: FGF2, FGFR2, TAOK3, PRKCA, MAPK1, CACNA1C
|
0.04893 |